IVUS Guidance in BTK Interventions

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorShin Kong Wu Ho-Su Memorial Hospital

About this trial

Chronic limb-threatening ischemia (CLTI) is a severe form of peripheral artery disease in which very poor blood flow in the arteries below the knee can cause rest pain, non-healing wounds, and even loss of the limb. It is often treated with endovascular therapy (EVT), a minimally invasive procedure that opens the blocked artery, but the artery frequently narrows or closes again afterward. These procedures are usually guided by X-ray pictures taken with dye (angiography). Intravascular ultrasound (IVUS) is an imaging tool that uses a small catheter inside the artery to give a more detailed view of the vessel, which may help doctors open it more completely. It is not yet clear whether adding IVUS improves results below the knee.

This study is testing whether guiding treatment with IVUS plus angiography keeps the artery open better than angiography alone. Adults aged 18 or older with CLTI who are having endovascular therapy for a blocked artery below the knee may take part. Participants are assigned by chance to be treated with either both imaging methods or angiography alone, and are followed for 12 months. The main question is how well the treated artery stays open at 6 months; researchers will also compare repeat procedures, amputation, complications, wound healing, survival, and quality of life.

Eligibility criteria

Qualifiers

Age ≥18 years.

Presence of ischemic symptoms compatible with CLTI, defined as arterial insufficiency with gangrene, non-healing ischemic ulcer, or rest pain consistent with Rutherford classes 4-5 AND

Imaging evidence within the past 12 months showing atherosclerotic PAD, including CTA, MRA, angiography or duplex ultrasound AND

Ankle-Brachial Index (ABI) ≤0.80 or Toe-Brachial Index (TBI) ≤0.60 for patients who never underwent revascularization; ABI ≤0.85 or TBI ≤0.65 for those with history of prior revascularization procedures OR

Disqualifiers

Age <18 years

Asymptomatic or mild disease: patients who underwent revascularization for disease graded Rutherford classes 0-3

Patients with major tissue loss (Rutherford 6) in whom major amputation was planned at the time of screening

Patient with a history of prior major (above-the-ankle) amputation of the study limb

Trial design

Treatments tested in this trial

  • Intravascular ultrasound-guided EVT
  • Angiography-guided EVT

Treatment groups

212 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Shin Kong Wu Ho-Su Memorial Hospital

Lead sponsor

National Taiwan University Hospital

Collaborator

Chi Mei Medical Hospital

Collaborator

Chang Gung Memorial Hospital

Collaborator

Taipei Veterans General Hospital, Taiwan

Collaborator